First modification:
Rilpivirine, and it is only recommended for people who, through daily antiretrovirals, have already managed to maintain a low viral load.
There are many initiatives that seek that people who are infected with HIV can have more comfortable treatment options.
In the United Kingdom, they are studying a therapy with injections that would serve to replace part of the pills that patients must take daily to keep the levels of the virus very low.
Professor Chloe Orkin, Queen Mary University of London, says that “offering the benefit of being able to choose a treatment for HIV has been one of the great successes of modern medicine, but taking this to the next level by reducing treatment from 365 days to six in a year is really a paradigm shift ”.
Those responsible for the initiative explain that the injectable treatment is a combination of Cabotegravir and Rilpivirine, and is only recommended for people who, through daily antiretrovirals, have already managed to maintain a low viral load.
The drugs have been tested for two years in 16 countries and show that when applied once a month, they are as effective as daily pills
.